Bone Marrow Transplantation. Vol.29, No.10 (2002), 871-872
Suggested Citation
S. Hongeng, P. Tardtong, S. Worapongpaiboon, A. Ungkanont, S. Jootar Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplantation. Vol.29, No.10 (2002), 871-872. doi:10.1038/sj.bmt.1703551 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20569
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab
Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-nondepleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.
